Asset Management Resources’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Asset Management Resources’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-138,020	Closed	-$122K	–	64
2022 Q4	$122K	Hold	138,020	–	–	0.08%	52
2022 Q3	$217K	Hold	138,020	–	–	0.21%	50
2022 Q2	$277K	Buy	138,020 +4,000	+3%	+$6.92K	0.24%	36
2022 Q1	$312K	Buy	134,020 +66,000	+97%	+$206K	0.25%	39
2021 Q4	$316K	Buy	+68,020	New	+$422K	0.28%	36

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

OFA

Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

LCM

Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return

STB

S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return

GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return

HFRG

Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

GBWM

Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Asset Management Resources's SRNE Position: Q1 2023 in Review

Asset Management Resources sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 138,020 shares — an estimated $122K sold.

Asset Management Resources first reported a position in SRNE in Q4 2021 and held it in 5 quarters. The position peaked at $316K in Q4 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

Asset Management Resources reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
Asset Management Resources sold 138,020 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $122K.
Asset Management Resources first reported a position in Sorrento Therapeutics, Inc. in Q4 2021 and held it in 5 quarters.
Asset Management Resources's Sorrento Therapeutics, Inc. position peaked at $316K in Q4 2021.
34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Asset Management Resources's 13F filing for Q1 2023, filed 11 Apr 2023.